Lixte Biotechnology Holdings Inc (LIXT)
2.86
+0.10
(+3.62%)
USD |
NASDAQ |
May 01, 16:00
2.87
+0.01
(+0.35%)
After-Hours: 20:00
Lixte Biotechnology Holdings Price to Book Value: 13.00 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 01, 2024 | 13.00 |
April 30, 2024 | 12.55 |
April 29, 2024 | 14.28 |
April 26, 2024 | 14.82 |
April 25, 2024 | 14.64 |
April 24, 2024 | 14.91 |
April 23, 2024 | 14.64 |
April 22, 2024 | 15.23 |
April 19, 2024 | 15.75 |
April 18, 2024 | 15.23 |
April 17, 2024 | 15.14 |
April 16, 2024 | 15.91 |
April 15, 2024 | 15.00 |
April 12, 2024 | 15.82 |
April 11, 2024 | 15.37 |
April 10, 2024 | 15.28 |
April 09, 2024 | 15.05 |
April 08, 2024 | 15.05 |
April 05, 2024 | 14.55 |
April 04, 2024 | 15.55 |
April 03, 2024 | 14.09 |
April 02, 2024 | 16.82 |
April 01, 2024 | 16.23 |
March 28, 2024 | 15.37 |
March 27, 2024 | 16.00 |
Date | Value |
---|---|
March 26, 2024 | 10.25 |
March 25, 2024 | 10.25 |
March 22, 2024 | 10.00 |
March 21, 2024 | 10.50 |
March 20, 2024 | 10.50 |
March 19, 2024 | 10.46 |
March 18, 2024 | 11.14 |
March 15, 2024 | 10.50 |
March 14, 2024 | 10.32 |
March 13, 2024 | 10.82 |
March 12, 2024 | 10.73 |
March 11, 2024 | 11.40 |
March 08, 2024 | 11.05 |
March 07, 2024 | 11.55 |
March 06, 2024 | 11.00 |
March 05, 2024 | 11.16 |
March 04, 2024 | 11.23 |
March 01, 2024 | 11.01 |
February 29, 2024 | 11.82 |
February 28, 2024 | 12.25 |
February 27, 2024 | 12.14 |
February 26, 2024 | 10.05 |
February 23, 2024 | 10.09 |
February 22, 2024 | 10.76 |
February 21, 2024 | 10.55 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.085
Minimum
Sep 23 2022
373.49
Maximum
May 24 2019
27.81
Average
9.877
Median
Oct 18 2021
Price to Book Value Benchmarks
iBio Inc | 0.7009 |
PAVmed Inc | -- |
PDS Biotechnology Corp | 5.067 |
Moleculin Biotech Inc | 0.4323 |
Syros Pharmaceuticals Inc | 8.637 |
Price to Book Value Related Metrics
Price | 2.86 |
Earnings Yield | -94.41% |
Market Cap | 6.433M |